ES2135416T3 - Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv. - Google Patents

Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv.

Info

Publication number
ES2135416T3
ES2135416T3 ES92922090T ES92922090T ES2135416T3 ES 2135416 T3 ES2135416 T3 ES 2135416T3 ES 92922090 T ES92922090 T ES 92922090T ES 92922090 T ES92922090 T ES 92922090T ES 2135416 T3 ES2135416 T3 ES 2135416T3
Authority
ES
Spain
Prior art keywords
piridopiridazinones
piridazinons
pde
compounds
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92922090T
Other languages
English (en)
Inventor
Robert Stephen Wilhelm
Bradley Earl Loe
Bruce Henry Devens
Robert Alvarez
Michael Grant Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Application granted granted Critical
Publication of ES2135416T3 publication Critical patent/ES2135416T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE HA DESCUBIERTO QUE LOS COMPUESTOS DE BENZO O PIRIDOPIRIDAZINONAS Y PIRIDAZINTIONAS DE LA FORMULA (I) EN LA QUE: X E Y SON NITROGENO O CARBONO, SIEMPRE Y CUANDO AL MENOS UNO DE ELLOS SEA CARBONO Y Z ES OXIGENO O AZUFRE; R1 ES HIDROGENO, ALKILO INFERIOR, ARILO, HETEROARILO O ALKILENO INFERIOR HETEROCICLICO; R2, R3, R4, R5 Y R6 SE SELECCIONAN INDEPENDIENTEMENTE DEL HIDROGENO, ALKILO INFERIOR, HALO, CARBOXI, ALCOXICARBONILO, CARBAMILO, ACILO, HALURO DE ACILO, TIOMETILO, TRIFLUOMETILO, CIANO O NITRO; O UN ESTER, ETER O SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS, SON UTILES COMO AGENTES ANTIINFLAMATORIOS, ANTIASMATICOS, INMUNOSUPERSORES, ANTI RECHAZO A LOS ALOINJERTOS, ANTI RECHAZO A LOS INJERTOS FRENTE A HUESPEDES, ENFERMEDADES AUTOINMUNES O ANALGESICOS.
ES92922090T 1991-10-09 1992-10-08 Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv. Expired - Lifetime ES2135416T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77567991A 1991-10-09 1991-10-09

Publications (1)

Publication Number Publication Date
ES2135416T3 true ES2135416T3 (es) 1999-11-01

Family

ID=25105161

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09201998A Expired - Fee Related ES2105920B1 (es) 1991-10-09 1992-10-08 Procedimiento para preparar compuestos de benzo-y piridopiridazinona y piridazinationa.
ES92922090T Expired - Lifetime ES2135416T3 (es) 1991-10-09 1992-10-08 Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES09201998A Expired - Fee Related ES2105920B1 (es) 1991-10-09 1992-10-08 Procedimiento para preparar compuestos de benzo-y piridopiridazinona y piridazinationa.

Country Status (20)

Country Link
EP (1) EP0612321B1 (es)
JP (1) JP3245165B2 (es)
KR (1) KR100263494B1 (es)
AT (1) ATE183745T1 (es)
AU (1) AU670544B2 (es)
CA (1) CA2117059C (es)
DE (1) DE69229874T2 (es)
DK (1) DK0612321T3 (es)
ES (2) ES2105920B1 (es)
FI (1) FI108229B (es)
GR (1) GR3030969T3 (es)
HU (2) HUT66969A (es)
IL (1) IL103388A (es)
MX (1) MX9205794A (es)
NO (1) NO302888B1 (es)
NZ (1) NZ244660A (es)
PT (1) PT100938B (es)
TW (1) TW365606B (es)
WO (1) WO1993007146A1 (es)
ZA (1) ZA927755B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200689D0 (en) * 1992-01-14 1992-03-11 Rhone Poulenc Agriculture New compositions of matter
GB9314412D0 (en) * 1993-07-13 1993-08-25 Rhone Poulenc Agriculture New compositions of matter
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
NZ291507A (en) * 1994-08-29 1997-12-19 Yamanouchi Pharma Co Ltd 1,8-naphthyridine derivatives; medicaments
GB9712761D0 (en) * 1997-06-17 1997-08-20 Chiroscience Ltd Quinolines and their therapeutic use
US6069151A (en) * 1996-11-06 2000-05-30 Darwin Discovery, Ltd. Quinolines and their therapeutic use
WO2001013953A2 (en) 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
PL191236B1 (pl) 1997-12-15 2006-04-28 Altana Pharma Ag Nowe pochodne dihydrobenzofuranowe, lek zawierający nową pochodną dihydrobenzofuranową oraz zastosowanie tych pochodnych do wytwarzania leków do leczenia schorzeń układu oddechowego lub do leczenia dermatologicznego
EP0934933A1 (en) * 1998-02-06 1999-08-11 Byk Gulden Lomberg Chemische Fabrik GmbH Phthalazinones
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
JP3270834B2 (ja) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
EA200300836A1 (ru) * 2001-02-15 2004-02-26 Алтана Фарма Аг Производные фталазинон-пиперидина в качестве ингибиторов pde4
AU2002315311B2 (en) 2001-04-25 2007-12-06 Altana Pharma Ag Piperazino-derivatives and their use as PDE4 inhibitor
HUP0303998A3 (en) 2001-04-25 2007-03-28 Altana Pharma Ag Phthalazinones derivatives and pharmaceutical compositions containing them
ES2195785B1 (es) 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
RS51445B (en) 2002-08-10 2011-04-30 Nycomed Gmbh. PYROLIDINDION SUBSTITUTED BY PIPERIDINE-PTHALAZONE AS PDE4 INHIBITORS
PL373597A1 (en) * 2002-08-10 2005-09-05 Altana Pharma Ag Piperidine-n-oxide-derivatives
ES2211344B1 (es) * 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2004087211A2 (en) 2003-04-01 2004-10-14 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
AU2005210042B2 (en) 2004-02-04 2011-04-21 Takeda Gmbh 2-(piperidin-4-yl) -4, 5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
ES2251866B1 (es) 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
PL383550A1 (pl) * 2007-10-15 2009-04-27 Uniwersytet Łódzki Nowe pochodne benzeno- i pirydopirydazynonów
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
KR102034748B1 (ko) 2011-03-01 2019-10-21 시너지 파마슈티컬즈 인코포레이티드 구아닐레이트 사이클라제 c 작용제의 제조 방법
US20130116241A1 (en) * 2011-11-09 2013-05-09 Abbvie Inc. Novel inhibitor compounds of phosphodiesterase type 10a
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
WO2014160440A1 (en) 2013-03-13 2014-10-02 Flatley Discovery Lab Pyridazinone compounds and methods for the treatment of cystic fibrosis
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
EP3884935B1 (en) 2013-08-09 2023-06-14 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP3265453B1 (en) * 2015-03-05 2022-06-29 Boehringer Ingelheim International GmbH New pyridinones and isoquinolinones as inhibitors of the bromodomain brd9
JP6837052B2 (ja) * 2016-03-09 2021-03-03 日本曹達株式会社 ピリジン化合物およびその用途
KR102250415B1 (ko) 2016-04-15 2021-05-11 애브비 인코포레이티드 브로모도메인 저해제
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
FR3105254B1 (fr) 2019-12-19 2022-08-12 Syctom Lagence Metropolitaine Des Dechets Menagers Installation et procédé de gazéification hydrothermale de biomasse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2805344B2 (ja) * 1989-07-11 1998-09-30 昭和電工株式会社 オレフィン重合触媒の製造方法およびオレフィンの重合方法
JP3120857B2 (ja) * 1990-02-19 2000-12-25 中外製薬株式会社 新規な縮合複素環化合物とこれを用いた抗喘息剤

Also Published As

Publication number Publication date
FI941567A (fi) 1994-04-06
NO302888B1 (no) 1998-05-04
IL103388A0 (en) 1993-03-15
NZ244660A (en) 1995-05-26
JPH07500321A (ja) 1995-01-12
WO1993007146A1 (en) 1993-04-15
PT100938B (pt) 1999-10-29
EP0612321B1 (en) 1999-08-25
ES2105920A1 (es) 1997-10-16
AU2781592A (en) 1993-05-03
NO941210L (no) 1994-04-05
HUT66969A (en) 1995-01-30
KR100263494B1 (ko) 2000-08-01
DE69229874T2 (de) 1999-12-09
JP3245165B2 (ja) 2002-01-07
NO941210D0 (no) 1994-04-05
ATE183745T1 (de) 1999-09-15
AU670544B2 (en) 1996-07-25
HU9400949D0 (en) 1994-06-28
IL103388A (en) 1997-09-30
GR3030969T3 (en) 1999-11-30
HU210814A9 (en) 1995-08-28
DE69229874D1 (de) 1999-09-30
DK0612321T3 (da) 1999-12-13
PT100938A (pt) 1993-10-29
CA2117059C (en) 2003-05-20
MX9205794A (es) 1993-04-01
EP0612321A1 (en) 1994-08-31
CA2117059A1 (en) 1993-04-15
FI941567A0 (fi) 1994-04-06
KR940702868A (ko) 1994-09-17
FI108229B (fi) 2001-12-14
ZA927755B (en) 1994-04-08
TW365606B (en) 1999-08-01
ES2105920B1 (es) 1998-07-01

Similar Documents

Publication Publication Date Title
ES2135416T3 (es) Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv.
CA2119572A1 (en) Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
FI953968A0 (fi) Antraniiliset happojohdannaiset
LV5748B4 (lv) Mikofenolskabes morfolinoetilesteris ta iegusana un pielietojums
ATE145906T1 (de) Benzamid-derivate
ES2113399T3 (es) Derivados de beta-oxo-beta-bencenopropano-tio-amida.
IE822310L (en) Triazoloquinazolone derivatives
TW360655B (en) Heterocyclyl-ergoline derivatives
FI89594C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull pyrrolidinfoerening
FI871253A0 (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
DK0471856T3 (da) 15-Deoxyprostaglandin-derivater
IE45587L (en) Diazepinoheterocyclic compounds
SE7713864L (sv) Nortropinkarbazatderivat och forfarande for framstellning av dem

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 612321

Country of ref document: ES